Plain-English translation of NCT06422871 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows patients who are receiving the HeRO Graft System or Super HeRO device as part of their regular dialysis care. These devices are used to help maintain long-term access for dialysis when standard options are no longer working. The study is tracking how well and safely these devices perform over time.
Patients with end-stage kidney disease need reliable access for dialysis treatment, but some people run out of standard options. This study exists to better understand how well this specialized graft system works for these patients and whether it's a safe, effective solution.
You likely qualify if…
You likely don't qualify if…
You would continue receiving your regular dialysis care with the graft device. Over 2 years, the study team will check in with you at up to 4 clinic visits to see how you're doing. If you can't make a clinic visit, they'll call you by phone to follow up on your health and dialysis status. This is mainly about tracking your progress rather than undergoing new procedures.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
United States